Green Thumb Industries (GTBIF) Shares Outstanding (Diluted Average) (2018 - 2026)
Green Thumb Industries (GTBIF) reported Shares Outstanding (Diluted Average) of $231.8 million for Q1 2026, down 2.11% on a YoY basis from $236.8 million in Q1 2025, and down 2.13% quarter-over-quarter from $236.9 million in Q4 2025.
Green Thumb Industries (GTBIF) Shares Outstanding (Diluted Average) (2018 - 2026) Analysis & Trends
Green Thumb Industries has reported Shares Outstanding (Diluted Average) for 9 years, with the latest figure at $231.8 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 2.11% year-over-year to $231.8 million; the trailing twelve-month figure through Mar 2026 stood at $231.8 million (down 2.11% YoY), and the FY2025 full-year result was $236.9 million, down 0.91% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $231.8 million, down from $236.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $240.6 million in Q1 2024, with the low at $231.8 million in Q1 2026.
- Historically, Shares Outstanding (Diluted Average) has averaged $237.7 million across 5 years, with a median of $238.1 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) climbed 7.49% — and 2026, when it dropped 2.11%.
- Green Thumb Industries' Shares Outstanding (Diluted Average) stood at $238.1 million in 2022, then climbed by 0.73% to $239.8 million in 2023, then dropped by 0.32% to $239.1 million in 2024, then slipped by 0.91% to $236.9 million in 2025, then retreated by 2.13% to $231.8 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $231.8 million (Q1 2026), $236.9 million (Q4 2025), and $233.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 231.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.83 Mn |
| Dec 31, 2025 | 236.87 Mn |
| Sep 30, 2025 | 233.54 Mn |
| Jun 30, 2025 | 235.84 Mn |
| Mar 31, 2025 | 236.82 Mn |
| Dec 31, 2024 | 239.06 Mn |
| Sep 30, 2024 | 238.30 Mn |
| Jun 30, 2024 | 240.14 Mn |
| Mar 31, 2024 | 240.56 Mn |
| Dec 31, 2023 | 239.83 Mn |
| Sep 30, 2023 | 240.29 Mn |
| Jun 30, 2023 | 238.42 Mn |
| Mar 31, 2023 | 237.69 Mn |
| Dec 31, 2022 | 238.08 Mn |
| Sep 30, 2022 | 237.80 Mn |
| Jun 30, 2022 | 237.76 Mn |
| Mar 31, 2022 | 238.23 Mn |
| Dec 31, 2021 | 226.76 Mn |
| Sep 30, 2021 | 230.88 Mn |
| Jun 30, 2021 | 224.84 Mn |